Urine biomarkers may detect disease state in NMIBC
October 28, 2019Read moreThe Scientific Programme of the EMUC congress is well-known for its broad coverage of relevant and current updates on...
0
Trial presentations to have “Guideline-changing potential”
August 14, 2019Read more“Onco-urology is a rapidly-evolving field. Next to classical systemic therapies such as androgen deprivation in prostate cancer or chemotherapy,...
What to do when faced with a nightmare PCa case
August 6, 2019Read moreImagine a treatment strategy not working on your patient. The situation escalates and the patient suffers from complications. What...
Keeping EMUC19 relevant for young onco-urology specialists
June 13, 2019Read moreA multidisciplinary approach to the treatment of urological cancers may have become more commonplace over the past decade, but...
EMUC18 addresses current dilemmas in mPCa treatment
November 12, 2018Read moreWhat is the role of cell-free circulating tumour DNA (ctDNA) in the treatment of metastatic prostate cancer (mPCa)? How...
Video: Update on POUT Trial
November 11, 2018Read moreDr. Alison Birtle (GB) discussed the updates on the trial to PeriOperative chemotherapy or sUrveillance in upper Tract urothelial...
Video: Radiomics: Images are more than pictures
November 10, 2018Read moreProf. Philippe Lambin (NL) and Dr. Jochen Walz (FR) discuss the emerging radiomic technologies. “Medical images hold more information than...
EMUC18 grants recognition to promising urologists
November 10, 2018Read moreFour promising urologists were granted awards at EMUC18 today. Chairs Dr. Jan Oldenburg (NO), Prof. Theo De Reijke (NL)...
New developments in PCa evaluation: Pathology & Radiomics
November 10, 2018Read moreEMUC prides itself on being a multidisciplinary meeting on genito-urinary cancers and one draw for the audience is the...
